Purification and Physical Characterization of Cloned Human cAMP Phosphodiesterases PDE-4D and -4C

Cell Biochemistry and Biophysics

Volumn 28, Issue 2-3, 1998, Pages 187-217

  Saldou, Natalie ^c   Baecker, Preston A ^a   Li, Bin ^a   Yuan, Zhengyu ^e   Obernolte, Rena ^a   Ratzliff, James ^a   Osen, Eric ^b   Jarnagin, Kurt ^a   Shelton, Earl R ^d  

^a ROCHE BIOSCIENCE   (United States)

^b Biotech   (United States)

^c GENENTECH INC   (United States)

^d Kowa Research Institute   (United States)

^e Versicor Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3',5' CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; HYBRID PROTEIN; ISOENZYME; PHOSPHODIESTERASE IV;

ARTICLE; BACULOVIRUS; CHEMISTRY; DIMERIZATION; GENE VECTOR; GENETICS; HUMAN; ISOLATION AND PURIFICATION; LIQUID CHROMATOGRAPHY; METABOLISM; METHODOLOGY; MOLECULAR CLONING; MOLECULAR WEIGHT;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; BACULOVIRIDAE; CHROMATOGRAPHY, LIQUID; CLONING, MOLECULAR; DIMERIZATION; GENETIC VECTORS; HUMANS; ISOENZYMES; MOLECULAR WEIGHT; RECOMBINANT FUSION PROTEINS;

EID: 0031606166     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02737811     Document Type: Article

References (53)

1. Beavo, J. A. and Reifsnyder, D. H. (1990) Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol. Sci. 11, 150-155.
2. Conti, M., Nemoz, G., Sette, C., and Vicini, E. (1995) Recent progress in understanding the hormonal regulation of phosphodiesterases. Endocr. Rev. 16, 370-389.
3. Beavo, J. A. (1995) Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol. Rev. 75, 725-748.
4. Beavo, J. A., Conti, M., and Heaslip, R. J. (1994) Multiple cyclic nucleotide phosphodiesterases. Mol. Pharmacol. 46, 399-405.
5. Alvarez, R., Sette, C., Yang, D., Eglen, R. M., Wilhelm, R., Shelton, E. R., and Conti, M. (1995) Activation and selective inhibition of a cyclic AMP-specific phosphodiesterase, PDE-4D3. Mol. Pharmacol. 48, 616-622.
6. Sette, C., Iona, S., and Conti, M. (1994) The short-term activation of a rolipram-sensitive, cAMP-specific phosphodiesterase by thyroid-stimulating hormone in thyroid FRTL-5 cells is mediated by a cAMP-dependent phosphorylation. J. Biol. Chem. 269, 9245-9252.
7. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. (1995) Current protocols in molecular biology, in Current Protocols (Janssen, K., ed.), John Wiley, New York.
8. Jin, S. L., Swinnen, J. V., and Conti, M. (1992) Characterization of the structure of a low Km, rolipram-sensitive cAMP phosphodiesterase. Mapping of the catalytic domain. J. Biol. Chem. 267, 18, 929-18, 939.
9. Bolger, G., Michaeli, T., Martins, T., St. John, T., Steiner, B., Rodgers, L., Riggs, M., Wigler, M., and Ferguson, K. (1993) A family of human phosphodiesterases homologous to the dunce learning and memory gene product of Drosophila melanogaster are potential targets for antidepressant drugs. Mol. Cell Biol. 13, 6558-6571.
10. Baecker, P. A., Obernolte, R., Bach, C., Yee, C., and Shelton, E. R. (1994) Isolation of a cDNA encoding a human rolipram-sensitive cyclic AMP phosphodiesterase (PDE IVD). Gene 138, 253-256.
11. O'Reilly, D. R., Miller, L. K., and Luckow, V. A. (1992) Baculovirus Expression Vectors: A Laboratory Manual, W. H. Freeman, New York, pp. 74-75.
12. Livi, G. P., Kmetz, P., McHale, M. M., Cieslinski, L. B., Sathe, G. M., Taylor, D. P., Davis, R. L., Torphy, T. J., and Balcarek, J. M. (1990) Cloning and expression of cDNA for a human low-Km, rolipram-sensitive cyclic AMP phosphodiesterase. Mol. Cell. Biol. 10, 2678-2686.
13. Obernolte, R., Bhakta, S., Alvarez, R., Bach, C., Zuppan, P., Mulkins, M., Jarnagin, K., and Shelton, E. R. (1993) The cDNA of a human lymphocyte cyclic-AMP phosphodiesterase (PDE IV) reveals a multigene family. Gene 129, 239-247.
14. Alvarez, R. and Daniels, D. V. (1992) A separation method for the assay of adenylylcyclase, intracellular cyclic AMP, and cyclic-AMP phosphodiesterase using tritium-labeled substrates. Anal. Biochem. 203, 76-82.
15. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
16. Conti, M., Iona, S., Cuomo, M., Swinnen, J. V., Odeh, J., and Svoboda, M. E. (1995) Characterization of a hormone-inducible, high affinity adenosine 3′-5′-cyclic monophosphate phosphodiesterase from the rat Sertoli cell. Biochemistry 34, 7979-7987.
17. Schilling, R. J., Morgan, D. R., and Kilpatrick, B. F. (1994) A high-throughput assay for cyclic nucleotide phosphodiesterases. Anal. Biochem. 216, 154-158.
18. Charbonneau, H. (1990) Structure-function relationships among cyclic nucleotide phosphodiesterases, in Cyclic Nucleotide Phosphodiesterases: Structure, Regulation and Drug Action (Beavo, J. and Houslay, M. D., eds.), John Wiley, New York, pp. 268-296.
19. Morrill, M. E., Thompson, S. T., and Stellwagen, E. (1979) Purification of a cyclic nucleotide phosphodiesterase from bovine brain using blue dextran-sepharose chromatography. J. Biol. Chem. 254, 4371-4374.
20. Giorgi, M., Piscitelli, D., Rossi, P., and Geremia, R. (1992) Purification and characterization of a low-Km 3′:5′-cyclic adenosine phosphodiesterase from post-meiotic male mouse germ cells. Biochim. et Biophys. Acta 1121, 178-182.
21. Nolte, C., Eigenthaler, M., Schanzenbaecher, P., and Walter, U. (1991) Endothelial cell-dependent phosphorylation of a platelet protein mediated by cAMP- and cGMP-elevating factors. J. Biol. Chem. 266, 14, 808-14, 812.
22. Mumby, M. C. and Scott, C. W. (1988) cAMP-dependent protein kinase regulatory subunit phosphorylation in intact cells. Methods Enzymol. 159, 139-146.
23. Thompson, W. J. (1991) Cyclic nucleotide phosphodiesterases: pharmacology, biochemistry and function. Pharmacol. Ther. 51, 13-33.
24. Nicholson, C. D. and Shahid, M. (1994) Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes - their potential utility in the therapy of asthma. Pulmonary Pharmacology 7, 1-17.
25. Raeburn, D. and Karlsson, J. A. (1993) Effects of isoenzyme-selective inhibitors of cyclic nucleotide phosphodiesterase on microvascular leak in guinea pig airways in vivo. J. Pharmacol. Exp. Ther. 267, 1147-1152.
26. Marchmont, R. J., Ayad, S. R., and Houslay, M. D. (1981) Purification and properties of the insulin-stimulated phosphodiesterase from rat liver plasma membranes. Biochem. J. 195, 645-652.
27. Thompson, W. J., Epstein, P. M., and Strada, S. J. (1979) Purification and characterization of a high affinity cyclic adenosine monophosphate phosphodiesterase from dog kidney. Biochemistry 18, 5228-5237.
28. Conti, M. and Swinnen, J. V. (1990) Structure and function of the rolipram-sensitive, low-Km cyclic AMP phosphodiesterases: a family of highly related enzymes, in Cyclic Nucleotide Phosphodiesterases: Structure, Regulation and Drug Action (Beavo, J. and Houslay, M. D., eds.), John Wiley, New York, pp. 243-266.
29. Truong, V. H. and Muller, T. (1994) Isolation, biochemical characterization and N-terminal sequence of rolipram-sensitive cAMP phosphodiesterase from human mononuclear leukocytes. FEBS Lett. 353, 113-118.
30. Swinnen, J. V., Tsikalas, K. E., and Conti, M. (1991) Properties and hormonal regulation of two structurally related cAMP phosphodiesterases from the rat Sertoli cell. J. Biol. Chem. 266, 18, 370-18, 377.
31. Torphy, T. J., Stadel, J. M., Burman, M., Cieslinski, L. B., McLaughlin, M. M., White, J. R., and Livi, G. P. (1992) Coexpression of human cAMP-specific phosphodiesterase activity and high affinity rolipram binding in yeast. J. Biol. Chem. 267, 1798-1804.
32. McLaughlin, M. M., Cieslinski, L. B., Burman, M., Torphy, T. J., and Livi, G. P. (1993) A low-Km, rolipram-sensitive, cAMP-specific phosphodiesterase from human brain. Cloning and expression of cDNA, biochemical characterization of recombinant protein, and tissue distribution of mRNA. J. Biol. Chem. 268, 6470-6476.
33. Wilson, M., Sullivan, M., Brown, N., and Houslay, M. D. (1994) Purification, characterization and analysis of rolipram inhibition of a human type-Iv(a) cyclic amp-specific phosphodiesterase expressed in yeast. Biochem. J. 304, 407-415.
34. Engels, P., Sullivan, M., Muller, T., and Lubbert, H. (1995) Molecular cloning and functional expression in yeast of a human cAMP-specific phosphodiesterase subtype (PDE IV-C). FEBS Lett. 358, 305-310.
35. Pillai, R., Kytle, K., Reyes, A., and Colicelli, J. (1993) Use of a yeast expression system for the isolation and analysis of drug-resistant mutants of a mammalian phosphodiesterase. Proc. Natl. Acad. Sci. USA 90, 11, 970-11, 974.
36. Swinnen, J. V., D'Souza, B., Conti, M., and Ascoli, M. (1991) Attenuation of cAMP-mediated responses in MA-10 Leydig tumor cells by genetic manipulation of a cAMP-phosphodiesterase [published erratum appears in J. Biol. Chem. Jan 25, 1992; 267(3), 2114]. J. Biol. Chem. 266, 14, 383-14, 389.
37. Sette, C., Vicini, E., and Conti, M. (1994) The ratPDE3/IVd phosphodiesterase gene codes for multiple proteins differentially activated by cAMP-dependent protein kinase. J. Biol. Chem. 269, 18, 271-18, 274.
38. Bates, M. D., Olsen, C. L., Becker, B. N., Albers, F. J., Middleton, J. P., Mulheron, J. G., Jin, S. L., Conti, M., and Raymond, J. R. (1993) Elevation of cAMP is required for down-regulation, but not agonist-induced desensitization, of endogenous dopamine D1 receptors in opossum kidney cells. Studies in cells that stably express a rat cAMP phosphodiesterase (rPDE3) cDNA. J. Biol. Chem. 268, 14, 757-14, 763.
39. Bologer, G. B., McPhee, I., and Houslay, M. D. (1996) Alternative splicing of cAMP-specific phosphodiesterase mRNA transcripts. Characterization of a novel tissue-specific isoform, RNPDE4A8. J. Biol. Chem. 271, 1065-1071.
40. Sullivan, M., Egerton, M., Shakur, Y., Marquardsen, A., and Houslay, M. D. (1994) Molecular cloning and expression, in both Cos-1 cells and S. cerevisiaea human cytosolic type-IVa, cyclic Amp specific phosphodiesterase (Hpde-IVa-H6. 1). Cellular Signaling 6, 793-812.
41. Amegadzie, B. Y., Hanning, C. R., McLaughlin, M. M., Burman, M., Cieslinski, L. B., Livi, G. P., and Torphy, T. J. (1995) Characterization of two human cAMP-specific phosphodiesterase subtypes expressed in baculovirus-infected insect cells. Cell Biol. Int. Rep. 19, 477-484.
42. Pollok, B., Fuog, E., Robbins, M., Fisher, D., Umland, J., Pillar, J., and Cheng, J. (1995) Baculovirus expression of human phosphodiesterase (PDE) IV isoenzymes; comparison with rPDE-IV produced immunization and bacterial expression systems, in Baculovirus and Insect Cell Gene Expression Conference, p. ST23, Chapman & Hall, Pinehurst, NC.
43. Torphy, T. J., DeWolf, W. E., Jr., Green, D. W., and Livi, G. P. (1993) Biochemical characteristics and cellular regulation of phosphodiesterase IV. Agents Actions Suppl. 43, 51-71.
44. de Mazancourt, P. and Giudicelli, Y. (1988) Brain low-Km cAMP phosphodiesterase. Methods Enzymol. 159, 766-772.
45. Nemoz, G., Moueqqit, M., Prigent, A. F., and Pacheco, H. (1989) Isolation of similar rolipram-inhibitable cyclic-AMP-specific phosphodiesterases from rat brain and heart. Eur. J. Biochem. 184, 511-520.
46. Clapham, J. C. and Wilderspin, A. F. (1994) Inhibition of isoenzymes of dog heart phosphodiesterase by blue, yellow and red triazine dyes. Biochem. Soc. Trans. 22, 216.
47. Edelstein, S. J. and Schachman, H. K. (1973) Measurement of partial specific volume by sedimentation equilibrium in H20-D2O solutions. Methods Enzymol. 27, 82-98.
48. Cohn, E. J. and Edsall, J. T. (1943) Proteins, Amino Acids and Peptides, Rheinhold, New York, pp. 374-377.
49. Francis, S. H., Colbran, J. L., McAllister-Lucas, L. M., and Corbin, J. D. (1994) Zinc interactions and conserved motifs of the cGMP-binding cGMP-specific phosphodiesterase suggest that it is a zinc hydrolase. J. Biol. Chem. 269, 22, 477-22, 480.
50. Sonnenburg, W. K., Seger, D., Kwak, K. S., Huang, J., Charbonneau, H., and Beavo, J. A. (1995) Identification of inhibitory and calmodulin-binding domains of the PDE1A1 and PDE1A2 calmodulin-stimulated cyclic nucleotide phosphodiesterases. J. Biol. Chem. 270, 30, 989-31, 000.
51. Thompson, W. J., Shen, C.-C., and Strada, S. J. (1988) Preparation of dog kidney high-affinity cAMP phosphodiesterase. Methods Enzymol. 159, 760-766.
52. Onali, P., Strada, S. J., Chang, L., Epstein, P. M., Hersh, E. M., and Thompson, W. J. (1985) Purification and characterization of high-affinity cyclic adenosine 5′-monophosphate phosphodiesterases from human acute myelogenous leukemic cells. Cancer Res. 45, 1384-1391.
53. Siegel, L. M. and Monty, K. J. (1966) Determination of molecular weights and frictional ratios of proteins in impure systems by use of gel filtration and density gradient centrifugation. Application to crude preparations of sulfite and hydroxylamine reductases. Biochim. Biophys. Acta 112, 346-362.